Green Dot Corporation Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Green Dot Corporation - GDOT
By:
Kahn Swick & Foti, LLC via
Business Wire
November 24, 2025 at 18:12 PM EST
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Green Dot Corporation (NYSE: GDOT) to Smith Ventures and CommerceOne Financial Corporation. Under the terms of the proposed transaction, shareholders of Green Dot will receive $8.11 in cash and 0.2215 shares of a new publicly traded bank holding company for each share of Green Dot that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company. If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nyse-gdot/ to learn more. To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com. CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn View source version on businesswire.com: https://www.businesswire.com/news/home/20251124723504/en/ Contacts
Kahn Swick & Foti, LLC
More NewsView More
Why Silver Beat Gold and the S&P in 2025—And What Comes Next ↗
Today 11:44 EST
NuScale's Shocking Q3 Was a Bullish Signal in Disguise ↗
Today 10:22 EST
Via MarketBeat
Is Netflix Making a Calculated Play for the Dow Jones? ↗
Today 9:32 EST
Recent QuotesView More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|